Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 14 February, 2020

Citadel Group

Form 8.3 - Allergan plc

RNS Number : 0516D
Citadel Group
14 February 2020
 
























 

Ap 19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.         KEY INFORMATION


























Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

Date of dealing

13 February, 2020

























2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security

                    dealt in (Note 3)









Long

Short

Common Stock  ISIN  IE00BY9D5467

Number        (%)

Number      (%)

(1) Relevant securities

640,624 (0.20%)

0 (0.00%)

(2) Derivatives (other than options)

3,809,048 (1.16%)

32,123 (0.01%)

(3) Options and agreements to purchase/sell

0 (0.00%)

200,000 (0.06%)

Total

4,449,672(1.36%)

232,123 (0.07%)



























 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

























Long

Short


Number        (%)

Number      (%)

(1) Relevant securities



(2) Derivatives (other than options)



(3) Options and agreements to purchase/sell



Total































Ap 20






























1.         DEALINGS (Note 4)

 

(a)        Purchases and sales





























Purchase/sale

Common Stock ISIN IE00BY9D5467

Number of securities

Price per unit (Note 5)

Purchase

220

199.2  USD

Purchase

100

199.22  USD

Purchase

25

199.23  USD

Purchase

135

199.24  USD

Purchase

5

199.245  USD

Purchase

350

199.26  USD

Purchase

100

199.27  USD

Purchase

14

199.39  USD

Purchase

92

199.395  USD

Purchase

4

199.4  USD

Purchase

241

199.49  USD

Purchase

400

199.5  USD

Purchase

2

199.51  USD

Purchase

100

199.52  USD

Purchase

100

199.525  USD

Purchase

4

199.53  USD

Purchase

119

199.54  USD

Purchase

296

199.61  USD

Purchase

100

199.76  USD

Purchase

205

199.8  USD

Purchase

200

199.98  USD

Purchase

300

200.11  USD

Purchase

400

200.2  USD

Purchase

9

200.25  USD

Purchase

100

200.26  USD

Purchase

167

200.27  USD

Purchase

95

200.3  USD

Purchase

214

200.34  USD

Purchase

214

200.35  USD

Purchase

343

200.36  USD

Purchase

321

200.38  USD

Purchase

198

200.39  USD

Purchase

983

200.4  USD

Purchase

100

200.41  USD

Purchase

200

200.47  USD

Purchase

500

200.48  USD

Purchase

262

200.55  USD

Purchase

426

200.57  USD

Purchase

100

200.58  USD

Purchase

98

200.65  USD

Purchase

582

200.66  USD

Purchase

100

200.69  USD

Purchase

100

200.71  USD

Purchase

100

200.81  USD

Purchase

200

200.84  USD

Purchase

285

200.84  USD

Purchase

67

200.92  USD

Purchase

200

200.93  USD

Purchase

600

200.94  USD

Purchase

110

200.97  USD

Purchase

45

201.02  USD

Purchase

231

201.04  USD

Purchase

40

201.055  USD

Purchase

274

201.06  USD

Purchase

422

201.07  USD

Purchase

575

201.09  USD

Purchase

85

201.1  USD

Purchase

50

201.15  USD

Purchase

40

201.16  USD

Purchase

100

201.16  USD

Purchase

150

201.18  USD

Purchase

35

201.19  USD

Purchase

98

201.29  USD

Sale

-100

199.44  USD

Sale

-610

199.5  USD

Sale

-200

199.53  USD

Sale

-100

199.54  USD

Sale

-300

199.55  USD

Sale

-114

199.58  USD

Sale

-435

199.6  USD

Sale

-100

199.62  USD

Sale

-173

199.63  USD

Sale

-95

199.65  USD

Sale

-505

199.69  USD

Sale

-100

199.71  USD

Sale

-100

199.72  USD

Sale

-100

199.8  USD

Sale

-115

199.83  USD

Sale

-166

199.84  USD

Sale

-108

199.94  USD

Sale

-8

199.97  USD

Sale

-100

199.98  USD

Sale

-116

200.01  USD

Sale

-46

200.05  USD

Sale

-100

200.2  USD

Sale

-221

200.21  USD

Sale

-157

200.22  USD

Sale

-176

200.23  USD

Sale

-500

200.24  USD

Sale

-600

200.3  USD

Sale

-100

200.33  USD

Sale

-120

200.34  USD

Sale

-582

200.35  USD

Sale

-100

200.36  USD

Sale

-100

200.37  USD

Sale

-488

200.38  USD

Sale

-300

200.39  USD

Sale

-165

200.4  USD

Sale

-100

200.41  USD

Sale

-200

200.42  USD

Sale

-100

200.44  USD

Sale

-100

200.45  USD

Sale

-25

200.47  USD

Sale

-166

200.48  USD

Sale

-277

200.5  USD

Sale

-225

200.52  USD

Sale

-101

200.53  USD

Sale

-100

200.54  USD

Sale

-100

200.56  USD

Sale

-180

200.58  USD

Sale

-400

200.67  USD

Sale

-308

200.69  USD

Sale

-200

200.7  USD

Sale

-600

200.72  USD

Sale

-100

200.74  USD

Sale

-29,991

200.74193  USD

Sale

-32

200.76  USD

Sale

-34

200.8  USD

Sale

-30

200.83  USD

Sale

-100

200.84  USD

Sale

-300

200.85  USD

Sale

-349

200.88  USD

Sale

-100

200.9  USD

Sale

-749

200.91  USD

Sale

-77

200.94  USD

Sale

-5

200.97  USD

Sale

-100

201.1  USD

Sale

-100

201.11  USD

Sale

-669

201.15  USD

Sale

-1,500

201.17  USD

Sale

-31

201.2  USD

Sale

-108

201.21  USD





















(b)        Derivatives transactions (other than options transactions)























Product name,

e.g. CFD

 ISIN

Nature of transaction

(Note 6)

 

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

























(c)        Options transactions in respect of existing relevant securities

 

(i)         Writing, selling, purchasing or varying


















Product name, e.g. call option

Writing, selling, purchasing,

varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type,

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(Note 5)



























(ii)        Exercising
























Product name,

e.g. call option

Number of securities

Exercise price per unit

(Note 5)






























(d)        Other dealings (including transactions in respect of new securities) (Note 4)




























Nature of transaction

(Note 8)

      Details

      Price per unit

      (if applicable) (Note 5)







 



















Ap 21

















2.         OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 
















Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated

None














Is a Supplemental Form 8 attached? (Note 9)


YES

















 Date of disclosure:

14 February, 2020

 Contact name:

Katie Bonds

 Telephone number:

020 7645 9700

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a





 








Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)











Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Put Option

Purchased

-200,000

160 USD

American

2/21/2020












Notes

 

1.          Where there are open option positions or open derivative positions (except for CFDs),  full details should be given. Full details of any existing agreements to urchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.








 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEGCGDDCXBDGGS

a d v e r t i s e m e n t